Human medicines European public assessment report (EPAR): MabThera, rituximab, Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell, Date of authorisation: 02/06/1998, Revision: 60, Status: Authorised

Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6

Levosalbutamol, salbutamol : List of nationally authorised medicinal products - PSUSA/000010330/202301

Training and resources for patients and consumers

CHMP early contact with patient and healthcare professional organisations process and FAQs

Human medicines European public assessment report (EPAR): Vyvgart, efgartigimod alfa, Myasthenia Gravis, Date of authorisation: 10/08/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Riltrava Aerosphere, formoterol fumarate dihydrate,glycopyrronium,budesonide, Pulmonary Disease, Chronic Obstructive, Date of authorisation: 06/01/2022, Revision: 3, Status: Authorised

Industry stakeholder platform meetings

Product-specific bioequivalence guidance

Pirfenidone product-specific bioequivalence guidance